Publication | Closed Access

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial

NeonatologyBronchopulmonary DysplasiaPediatricsPediatric Lung DiseaseMaternal HealthPreterm BirthNewborn MedicineEarly Low-dose HydrocortisoneMedicinePreterm Infants